Search

everythinglearnresearchcommunity

for

Search:↓

L-threonate may help prevent balding by blocking a key hair loss factor.

A rabbit with sebaceous adenitis was effectively treated with ciclosporin and medium-chain triglycerides.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Introducing the rat OTC gene normalized hair growth in SPF-ASH mice.

AMT® is effective and safe for early-stage knee osteoarthritis.

Certain gene variations are linked to the thickness of cashmere goat hair.

Platelet-rich plasma therapy is seen as a promising tissue repair method but lacks standardized protocols.

RXRα is crucial for hair growth and skin cell function.

Adding a second method to PROTACs could improve cancer treatment.

RF-mesotherapy with dutasteride may be a promising alternative treatment for hair loss.

Reflectance confocal microscopy may help diagnose trichofolliculoma by showing specific skin features.

The newborn with Klippel-Trénaunay syndrome was healthy but needed regular check-ups for possible complications.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Radiotherapy is a good option when further surgery for skin cancer isn't preferred, but more research is needed to compare it with other methods.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

RCS-01 cell therapy is safe and improves skin gene expression.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

DermaCult™ Keratinocyte Expansion Medium allows human skin cells to grow longer while keeping their ability to develop properly.

Sgk3 is essential for normal hair follicle growth and maintenance.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Temporal triangular alopecia is a harmless, non-progressive hair loss condition.

RORs may influence cashmere growth cycles.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

PRS injections can improve knee function and reduce pain for up to a year.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Topical Ruxolitinib may safely treat severe hair loss.